Connect with us
DAPA Banner

Crypto World

5 Applications of Blockchain in the Healthcare Industry

Published

on

5 Applications of Blockchain in the Healthcare Industry

Digital transformation in healthcare has had a positive impact on technology in healthcare. Wearable fitness technology, telemedicine, and artificial intelligence-enabled medical devices are all concrete examples of digital transformation in healthcare. These are all supposed to revolutionize the healthcare industry by improving patient care, streamlining operations, and reducing costs but instead, the industry faces significant challenges in terms of cybersecurity and privacy of patient data, billing, payment processing, medical supply chain, and drug integrity. 


Blockchain technology can absolve the healthcare industry from facing these challenges, as you can establish a blockchain of medical records.


Blockchain is considered to be highly secure, transparent and immune to hackers due to its digital encryption; it also plays a prominent role in lowering intermediate fees as it is entirely decentralized.


Now, let’s see the 6 key applications of Blockchain in healthcare! 

Advertisement


1. Healthcare Data Exchange and Interoperability

The Healthcare Information and Management Systems Society (HIMSS) has developed a definition of interoperability. As per HIMSS, interoperability has three levels.

  • Foundational – At this level, Health Information Technology (HIT) systems exchange information without the ability to interpret the data.
  • Structural – This is the middle layer that defines the data formats exchanged between HIT systems, while also retaining the syntactic meaning of the data.
  • Semantics – This is a topmost layer, where HIT systems send and receive data, and interpret data meaningfully by using standardized codes.


For the real machine to machine interoperability of EHR systems the system must fulfill all the above requirements. In addition, data privacy is a big concern among healthcare stakeholders; hence any system that supports the interoperability of EHR must support permissions, trust and data security.


Blockchain provides a mechanism to anonymize data and ensures this data cannot be tampered with or forged. Blockchain uses public-key cryptography to create records that are time-stamped and immutable. Copies of these data records are then stored across thousands of nodes on a digital network. Changing these records at each node becomes an impossible task and prohibitively expensive, making the records reliable. The trust network created in this manner is among the most attractive features of the technology.


2. Drug supply chain management

Advertisement

Effective supply chain management is the biggest challenge in all industries. However, there is both additional risk and complexity in healthcare, as a compromised supply chain can affect patient safety. The increasing adoption of technology and globalization in a multi-stakeholder industry has resulted in a complicated healthcare supply chain.


The pharmaceutical supply chain is prominent in the damaged areas of the health supply chain. An IQVIA

Institute Study says that the worldwide pharmaceutical market will exceed USD 1.5 trillion by 2023. The OECD has found counterfeit goods that account for 3.3 percent of the global pharmaceutical drug trade.


Experts have estimated that the sale of counterfeit drugs is twice the legal pharmaceutical trade rate, which means it is a severe issue.


With its transparent, immutable and auditable nature, the pharma blockchain holds the potential to enhance the supply chains:

Advertisement
  • Security
  • Integrity
  • Data provenance
  • Functionality


3.  Prescription Drug Abuse

Drug abuse is a global epidemic, and real people are suffering. The UN estimates that there are 29.5 million people worldwide with drug use disorders.


What makes this scarier is that much of the drug problem is not in seedy alleys, crack houses or even Hollywood mansions. Part of solving this problem will be ensuring that the right medicine only reaches the people who need it. The healthcare industry has turned to technology to help address the problem.


The healthcare industry is using Blockchain to solve this problem and projects like MediLedger and BlockMedx are leveraging blockchain technology to bring security and transparency to pharmaceutical supply chains.


Blockchain startup BlockMedx has been working on an end-to-end prescription platform using the Ethereum blockchain. This platform uses an intelligent system that uses cryptographic tokens to facilitate transactions. Prescriptions transmitted via the platform can then be verified along with physician and patient data.

Advertisement


Doctors will be able to explore their own prescription history and even revoke prescriptions if they think something is wrong. Pharmacies could also make sure that they are filling legitimate prescriptions.


4. Health Insurance 


According to

Deloitte, health and life insurers are among the many players who are scrambling to determine how Blockchain could be adapted to improve the way that they maintain records, execute transactions, and interact with stakeholders. Key questions center on whether Blockchain’s unique attributes could help insurers to cut costs, manage risk, improve customer service, grow their business, and, ultimately, bolster the bottom line.


Deloitte’s

Center for Health Solutions and
Center for Financial Services have recently partnered on a crowdsourcing research project to examine how health and life insurers might leverage Blockchain and related technologies in order to strengthen key elements of an insurer’s value proposition. The crowd’s mission was to brainstorm how insurers could apply this emerging technology in the next five to 10 years to improve current standard operating procedures and systems while also enhancing the customer experience.

Advertisement


They found six use cases that are the most realistic and promising for health and life insurers:

  • Moving towards interoperable, comprehensive health records 
  • Supporting administrative and strategic imperatives with smart contracts
  • Detecting fraud more effectively
  • Improving provider directory accuracy
  • Simplifying the application process by making it more client-centric
  • Facilitating a dynamic insurer/client relationship

5. Clinical Trials


The risky and unpredictable nature of the clinical trial process has been a significant driver of high costs for pharmaceutical drugs. To justify drug development costs, most pharmaceutical companies aim to develop 2-3 new medicines per year, but the success rate and prolonged development timelines with clinical trials are diminishing the chances of a successful product to nearly zero.


This huge uncertainty translates into higher prices for everyone, from the investigator to the end consumer. Fortunately, Blockchain is attracting significant attention in the research community.


Blockchain technology utilizes a distributed computer network platform that enables databases to store time-stamped transaction records and documents. Blockchain is a safe and secure platform for storing and processing all types of valuable information, from clinical trial analysis results to business workflow documents to patients’ medical data and blueprints of genetic information. 

Advertisement


The uptake of this technology could save the healthcare industry up to $100 billion per year by 2025 in data breach-related costs, including IT costs, operations costs, support function and personnel costs, counterfeit related frauds and insurance frauds. One of the biggest beneficiaries of the technology will be pharmaceutical companies, which lose approximately $200 billion to counterfeit drugs each year. By enabling complete visibility and transparency throughout the drug supply chain, Blockchain will enable the tracking of drugs to their point of origin and thus help to eliminate falsified medication. 

However, a shift to blockchain-based solutions will require significant investments and efforts, including seamless integration with the current infrastructure, and blockchain providers may experience resistance from healthcare players for changing from legacy systems and processes to Blockchain. Industry alignment is necessary for bringing in standardization and promoting interoperability between different networks developed by various enterprises that run on different consensus protocols.

Want to know how to apply a tech solution in your healthcare business? Contact us!

Source link

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Institutional Investors Plan More Crypto Exposure in 2026: Survey

Published

on

Institutional Investors Plan More Crypto Exposure in 2026: Survey

The crypto market sell-off since October hasn’t deterred institutional investors, with a new survey showing most plan to increase exposure to digital assets in the coming year.

According to a January survey of 351 institutional investors conducted by Coinbase and EY-Parthenon, 73% of respondents said they plan to increase their allocations of digital assets in 2026, while 74% expect crypto prices to rise over the next 12 months.

Two-thirds of respondents said exchange-traded products (ETPs) and other regulated vehicles have become their preferred way to gain exposure, reflecting growing familiarity with these instruments and a broader shift toward regulated access points. Regulation was also cited as a key factor attracting institutional participation.

On the regulatory front, more than three-quarters of respondents cited market structure as the most important area requiring clarity — a concern that comes as US lawmakers continue to debate legislation defining how digital assets are classified and regulated across agencies.

Advertisement

Market volatility, however, is reshaping how institutions approach crypto. Nearly half (49%) of respondents said recent turbulence has led them to place greater emphasis on risk management, liquidity and position sizing, rather than reducing exposure.

Investments in crypto ETPs and digital asset companies remain among the most-common approaches for institutional exposure. Source: Coinbase-EY

Related: Crypto’s 2026 investment playbook: Bitcoin, stablecoin infrastructure, tokenized assets

Stablecoins, tokenization gain traction

One of the key takeaways from the survey is growing institutional interest in emerging blockchain use cases such as stablecoins and tokenized real-world assets (RWAs).

According to the findings, 85% of respondents use or plan to use stablecoins for payments and treasury operations, with settlement and internal cash management cited as primary use cases.

Part of that momentum is being driven by US regulatory developments, with 83% of respondents saying the passage of the GENIUS Act will increase financial institutions’ willingness to engage with stablecoins. More than two-thirds (69%) said the law will drive broader adoption of stablecoin-based transactions.

Advertisement
The passage of the GENIUS Act is seen as a catalyst for broader adoption of stablecoins. Source: Coinbase-EY

Meanwhile, interest in tokenized assets continues to grow, with 63% of investors expressing interest in gaining exposure and 61% expecting tokenization to have a significant impact on market structure in the coming years.

Related: SEC’s ‘Crypto Mom’ calls for simpler disclosure rules, flags tokenization debate